Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer—a prospective national multicentre study (EMIT-1)
-
Published:2024-06
Issue:6
Volume:9
Page:103475
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Ohnstad H.O.ORCID, Blix E.S.ORCID, Akslen L.A., Gilje B., Raj S.X.ORCID, Skjerven H.ORCID, Borgen E., Janssen E.A.M.ORCID, Mortensen E., Brekke M.B., Falk R.S.ORCID, Schlichting E.ORCID, Boge B., Songe-Møller S., Olsson P., Heie A., Mannsåker B.ORCID, Vestlid M.A., Kursetgjerde T., Gravdehaug B., Suhrke P.ORCID, Sanchez E., Bublevic J.ORCID, Røe O.D.ORCID, Geitvik G.A., Halset E.H., Rypdal M.C., Langerød A., Lømo J., Garred Ø., Porojnicu A.ORCID, Engebraaten O., Geisler J.ORCID, Lyngra M., Hansen M.H.ORCID, Søiland H., Nakken T., Asphaug L., Kristensen V., Sørlie T., Nygård J.F.ORCID, Kiserud C.E., Reinertsen K.V., Russnes H.G., Naume B.ORCID
|
|